Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27

S Turakhia, CD Venkatakrishnan… - … of physiology-heart …, 2007 - journals.physiology.org
The use of doxorubicin (Dox) and its derivatives as chemotherapeutic drugs to treat patients
with cancer causes dilated cardiomyopathy and congestive heart failure due to Dox-induced …

Analysis of peripheral T-cell lymphoma diagnostic workup in the United States

ED Hsi, SM Horwitz, KR Carson… - … Myeloma and Leukemia, 2017 - Elsevier
Background With increased understanding of the unique entities, subtype-specific
approaches for peripheral T-cell lymphoma (PTCL) are emerging, and more precise …

Aggressive B-Cell Lymphomas With Translocations Involving BCL6 and MYC Have Distinct Clinical-Pathologic Characteristics

SK Turakhia, BT Hill, SD Dufresne… - American Journal of …, 2014 - academic.oup.com
Objectives: Recently described, aggressive B-cell lymphomas with genetic abnormalities
involving MYC and BCL2 have been shown to have a poor prognosis when treated with …

Immunohistochemistry for BRAF V600E in the Differential Diagnosis of Hairy Cell Leukemia vs Other Splenic B-Cell Lymphomas

S Turakhia, C Lanigan, F Hamadeh… - American Journal of …, 2015 - academic.oup.com
Objectives: Recent reports have used immunohistochemistry (IHC) with a mutation-specific
antibody to detect the BRAF V600E mutation, which is found in nearly all cases of hairy cell …

Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations

SK Turakhia, G Murugesan, CV Cotta… - Journal of Clinical …, 2016 - jcp.bmj.com
Aims Marked thrombocytosis is uncommon in chronic myelogenous leukaemia (CML) but
may be associated with mutation of JAK2 V617F, calreticulin (CALR) and/or phospho-STAT5 …

A multicolour flow cytometric assay for c-MYC protein in B-cell lymphoma

K Alayed, K Schweitzer, A Awadallah… - Journal of Clinical …, 2018 - jcp.bmj.com
Aim Develop an objective assay to detect c-MYC protein expression using multiparametric
flow cytometry (FCM) as an alternative to immunohistochemistry (IHC). Methods 57 patient …

[CITATION][C] Doxorubicin-induced cardiotoxicity

S Turakhia, CD Venkatakrishnan, K Dunsmore… - American Journal of …, 2007

[CITATION][C] Thrombocytosis and STAT5 Activation in Chronic Myelogenous Leukemia Are Not Associated With JAK2 V617F or Calreticulin Mutations

S Turakhia, G Murugesan… - …, 2015 - … GROUP 75 VARICK ST, 9TH FLR …

[CITATION][C] Low CD177 (%) on Neutrophils Correlates with Granulocytic Dysplasia and Adds Value for Identifying Myelodysplasia by Flow Cytometry

S Turakhia, HJ Meyerson - …, 2016 - … GROUP 75 VARICK ST, 9TH FLR …

[CITATION][C] Multi-Color Flow Cytometric Analysis of c-MYC Protein in B-Cell Lymphomas, a Correlation Study with Immunohistochemistry and FISH

K Alayed, K Schweitzer… - …, 2016 - … GROUP 75 VARICK ST, 9TH FLR …